For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.
By Dr. Chinta Sidharthan The researchers evaluated budesonide-glycopyrrolate-formoterol and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback